Hypertension Flashcards
AHA goals
Most with CVD :<140/90
Drugs that cause or worsen hypertension
ACTH, alcohol, amphetamines, appetite suppressants, caffeine, Calcineurin antagonists (cyclosporine, tacrolimus), corticosteroids, decongestants, erythropoietin stimulating agents, estrogen, herbals (ginseng, guarana, St. John’s wort), mirabegron (mybetriq), NSAIDs, oncology drugs, SNRIs, thyroid hormone
Lifestyle modifications
- Weight control
- Eating: DASH (high in fruits and veggies, low fat dairy, reduced sat. And total fat, reduced salt)
- Reduced sodium intake: <2.4g /day
- Inc. Physical activity
- Alcohol limits 1/day women and 2/day men
- Smoking cessation
- CONTROL GLUCOSE AND LIPIDS TO REDUCE CV RISK
First line per JNC8
- African Americans and elderly: CCB or thiazide
- White: ACE, ARB, CCB, THIAZIDE
- CKD/Diabetes: ACE or ARB
Goals per JNC 8
REVIEW
Thiazides
Inexpensive, effective
MOA: work on DCT of the nephron and cause vasodilation (inhibit Na re absorption in the DCT causing inc. Sodium , potassium, H+ and water excretion)
Drugs: chlorthalidone (thalitone), HCTZ (microzide), metolazone (zaroxolyn), indapamide
Contra: hypersensitivity to Sulfa, anuria, and renal decompensation
Warning: sulfa allergy, electrolyte disturbances
Side effects: hypokalemia, hyperuricemia, elevated lipids, hyperglycemia, hypercalcemia, hyponatremia, hypomag, dizziness, photosensitivity, rash
Notes: May not be effective in pts with CrCl <30
Pregnancy category B
Loops
Waste more potassium than others (May need supplement)
Mostly used for fluid in HF
MOA: inhibit reabsorption of Na and Cl in the thick ascending loop of Henle thus inc water excretion
Drugs: furosemide (lasix), bumetanide, torsemide (demadex), ethacrynic acid (edecrin)
Equivalency: (40:1:20:50)
BBW: profound dieresis
Warnings: sulfa allergy on all but ethacrynic acid
Side effects: hypokalemia, orthostatic hypotension, dec (Na, Mg, Cl, Ca), metabolic alkalosis, hyperuricemia, hyperglycemia, inc cholesterol, photosensitivity, ototoxicity, including hearing loss, tinnitus and vertigo (most with ethacrynic acid)
Monitoring: renal function, fluid status, BP, electrolytes, hearing
Notes: IV formulations are light sensitive (amber bottle); IV:PO for torsemide and bumetanide 1:1
Potassium Sparing Diuretics
MOA: compete with aldosterone in DCT and collecting ducts increasing Na and water excretion while conserving potassium and H+
Drugs: amiloride (midamor), triamterene (dyrenium)(+ HCTZ is maxzide or dyazide), spironolactone (aldactone), eplerenone (inspra)
BBW: tumor risk (spironolactone)
Contra: renal impairment (CrCl <30), hyperkalemia
Side effects: hyperkalemia, inc. SCr
Spironolactone specific SE: gynecomastia, breast tenderness, impotence
Monitoring: check K+ before starting, BP, Scr/BUN
Diuretic drug interactions
Loops can inc the ototoxic potential of other ototoxic drugs such as aminoglycosides and vancomycin and should not be used in comb with ethacrynic acid
Monitor if used win lithium as can inc toxicity
Avoid with NSAIDs as they inc Na & h2o retention
RAAS inhibitors
Reduce vasoconstriction, decrease aldosterone release, and some agents have shown benefit in renal protection and heart failure
Caution if using two RAAS agents together such as an ace inhibitor, ARB, and Aliskiren. (monitor renal function, BP and potassium carefully)
Major side effects with an ACE inhibitor or an ARB
Cough and angioedema (more common with an ace inhibitor)
Angioedema is a contraindication to any other agent in this class
Angioedema is most common in black patients and signs and symptoms include swelling of the lips, mouth, tongue, face, or neck
Pregnancy considerations with RAAS inhibitors
Contraindicated
ACE-Inhibitors
MOA: inhibit the angiotensin-converting enzyme preventing the conversion of angiotensin I to angiotensin II a potent vasoconstrictor thereby reducing blood pressure
Drugs: benazepril (Lotensin), captopril (Capoten), enalapril (Vasotec), lisinopril (prinivill, zestril), quinapril (accupril), Ramipril (Altace)
Benazepril and enalapril are twice-daily dosing most others are once daily
Blackbox warning: discontinue in pregnancy
Contraindications: angioedema, bilateral renal artery stenosis, cannot use concurrently with Aliskiren in patients with diabetes
Warning: caution when using more than one RAAS agent at the same time due to risk of hypertension, hyperkalemia, renal dysfunction
Side effects: cough, hyperkalemia, angioedema, hypotension, dizziness and acute renal insufficiency (captopril has many more SEs such as taste perversion and rash)
Monitoring: blood pressure, potassium, renal function
Notes: pregnancy category D
ARBs
MOA: block angiotensin II from binding to the angiotensin II receptor on vascular smooth muscle and thus preventing vasoconstriction
Drugs: valsartan (Diovan), losartan (Cozaar), irbesartan (Avapro), candesartan (Atacand), Olmesartan (Benicar), telmisartan (micardis), azilsartan (Edarbi)
Blackbox warning: do not use in pregnancy
Contraindications: angioedema, bilateral renal artery stenosis, do not use with Aliskiren in patients with diabetes
Warning: caution with other RAAS agents; (Olmesartan only: spruce like enteropathy (severe diarrhea))
Side effects: angioedema, hyperkalemia, hypertension, dizziness and acute renal insufficiency
Monitoring: BP, potassium, renal function
Notes: pregnancy category D
Direct Renin Inhibitor
MOA: directly inhibits renin which is responsible for the conversion of angiotensinogen to angiotensin one a potent vasoconstrictor thereby reducing BP
Drug: Aliskiren (Tekturna)
Blackbox warning: discontinue in pregnancy